ロード中...
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals
It is unclear whether eradication of hepatitis C virus (HCV) leads to a reduction in the risk of hematologic malignancies. We aimed to determine the impact of sustained virologic response (SVR) induced by either direct‐acting antivirals (DAAs) or interferon (IFN) on the risk of hematologic malignanc...
保存先:
| 出版年: | Hepatol Commun |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6671776/ https://ncbi.nlm.nih.gov/pubmed/31388632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1389 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|